シナプトジェニクス・インク | 10-Q：Q3 2024 四半期報告書

SEC11/13 06:05

Telesis Bio TBIO Delisting; Synaptogenix SNPX Offering

BioPharmCatalyst09/12 04:01

Synaptogenix Enters Into Securities Purchase Agreements For A $5M Financing With Existing Investors Involving The Sale Of 5,000 Shares Of Its Newly Issued Series C Convertible Preferred Stock, With A Stated Value Of $1,000 Per Share; The Shares Of...

Benzinga09/11 21:07

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga09/02 20:05

シネプトジェニックス インク | 10-Q：Q2 2024 四半期報告書

SEC08/15 04:37

Synaptogenix Price Target Announced at $14.00/Share by Maxim Group

Dow Jones07/11 21:18